Zi xiu tang pollen capsule in addition weight-loss challenges

Recently, VIVUS is difficult proxy battle to claim the creation of a board of 11 new members, including Zook revolt of some sort, and the expulsion of top management, were resolved in favor of Manhattan Corporation FMC first investors of 9.9% finally zi xiu tang pollen capsule executive of AstraZeneca PLC former has commercialized some drugs that successfully suffered through. In order to provide the expertise required for turnaround carefully according to the FMC, the new board was selected. The FMC, one of the board members chosen non-FMC-four only if you have launched a campaign of its activities, Mark Logan, was appointed in April before.

But proxy battle was raging,, VIVUS has started to make progress in the launch of the Qsymia. The company, as Duane Reade, Inc. independent pharmacy and Walgreen's, such as those signed up, in the fourth quarter, official retail pharmacy of more than 10,000, including retail chains and country, and, come on board The company said. With the expansion of access to retail, from the range of $ 65, the company, working with insurance zixiutang bee pollen capsule companies to bring down the self-pay to $ 35 from friendly $ 25 to more consumers from the previous $ 50 You.

You must be more delicious franchise a big pharmaceutical partners increase decrease co-pay, and access. Prescription most active endocrine, plus, VIVUS has increased the number of 39% prescribing physician to about 21,000.